Microarray-based molecular diagnostics: An application to predicting prostate cancer aggressiveness.

被引：0
|
作者：
Moraleda, J [1 ]
Buturovic, L [1 ]
Tran, Q [1 ]
Pattin, A [1 ]
Anderson, G [1 ]
机构：
[1] PathWork Informat, San Jose, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：872S / 872S
页数：1
相关论文
共 50 条
  • [1] Linkage analysis on prostate cancer aggressiveness.
    Slager, SL
    Schaid, DJ
    Cunningham, JM
    McDonnell, SK
    French, A
    Peterson, BJ
    Marks, AF
    Hebbring, S
    Koch, B
    Anderson, S
    Thibodeau, SN
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 247 - 247
  • [2] History of PSA screening on prostate cancer aggressiveness.
    Cullen, Jennifer
    Gerald, Thomas
    Burke, Allen
    Kuo, Huai-Ching
    Rosner, Inger L.
    Srivastava, Shiv
    Sesterhenn, Isabell
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Alternative RNA splicing and prostate cancer aggressiveness.
    Al Abo, Muthana
    Patierno, Steven R.
    Freedman, Jennifer A.
    [J]. CANCER RESEARCH, 2018, 78 (16) : 111 - 112
  • [4] Bioorthogonal fluorescent probe for molecular imaging of cancer aggressiveness.
    Erkan, H.
    Telci, D.
    Dilek, O.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [5] Exploration of alternative digit ratios as a predictor of prostate cancer aggressiveness.
    Stolten, Michael
    Ledet, Elisa
    Dotiwala, Aryeneesh
    Luk, Eric
    Sartor, A. Oliver
    Wood, Byron
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [6] Microarray-Based Genomic DNA Profiling Technologies in Clinical Molecular Diagnostics
    Shen, Yiping
    Wui, Bai-Lin
    [J]. CLINICAL CHEMISTRY, 2009, 55 (04) : 659 - 669
  • [7] A microarray-based study of DNA methylation changes in prostate cancer
    Schwartzman, Jacob
    Mongoue-Tchokote, Solange
    Zarour, Luai
    DeMarzo, Angelo
    Bova, G. Steven
    Mori, Motomi
    Alumkal, Joshi J.
    [J]. CANCER RESEARCH, 2010, 70
  • [8] A novel live cell platform utilizing phenotypic biophysical and molecular biomarkers for assessing prostate cancer aggressiveness.
    Knopf, Kevin B.
    Rieger-Christ, Kimberly M.
    Sullivan, Travis B.
    Kella, Naveen
    Hernandez, Ray
    Rashid, Hani H.
    Mouraviev, Vladimir
    Manak, Michael S.
    Su, Wendell R.
    Min, Andrew
    Berger, Delaney
    Hogan, Brad J.
    Saphirstein, Robert J.
    Whitfield, Matt J.
    Varsanik, Jonathan S.
    Foroohar, Mani
    Albala, David
    Chander, Ashok C.
    Sant, Grannum R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
    Perot, Philippe
    Cheynet, Valerie
    Decaussin-Petrucci, Myriam
    Oriol, Guy
    Mugnier, Nathalie
    Rodriguez-Lafrasse, Claire
    Ruffion, Alain
    Mallet, Francois
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (81):
  • [10] FDA perspectives on potential microarray-based clinical diagnostics
    Težak Z.
    Ranamukhaarachchi D.
    Russek-Cohen E.
    Gutman S.I.
    [J]. Human Genomics, 2 (4) : 236 - 243
12345